Tapewire

Nasdaq · USD

CLOV

CLOVER HEALTH INVESTMENTS, CORP. /DE

Export transactions ↓
Tapewire entity
4419
SEC CIK
0001801170
Parsed reports
342

Last 12 months

Inside the activity.

0 purchase rows · 35 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202501
Dec 202501
Jan 202602
Feb 202600
Mar 202602
Apr 202600
May 202603
Jun 202605
Jul 2026010
Aug 202602
Sep 202606
Oct 202603

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
January 07, 2024 Filed Jan 9, 2024 21:05 UTC
Garipalli VivekDirector · 10% owner
Exercise / conversionClass B Common Stock · Derivative 1,561,065 Not disclosed Not disclosed
Disclosure

SEC source: 0001801170-24-000039 · wk-form4_1704834283.xml · derivative · entry 5

Garipalli Vivek · CIK 0001839260 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,232,610

Underlying: Class A Common Stock · 1,561,065 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: The Issuer's Class B Common Stock is convertible into shares of the Issuer's Class A Common Stock on a one-to-one basis at the option of the holders of the Issuer's Class B Common Stock at any time upon written notice to the Issuer, and automatically in the event of certain transfers, including, but not limited to, a transfer of shares to the Issuer.

F2 · derivative.exercise_price: On January 7, 2024, 20% of the original number of restricted stock units ("RSUs") in respect of a Class B Common Stock granted to the Reported Person on January 7, 2021 vested, with 1,781,633 shares of the Issuer's Class B Common Stock being delivered to the Reporting Person and 1,561,065 shares of the Issuer's Class B Common Stock automatically converting into an equal number of shares of the Issuer's Class A Common Stock and being withheld by the Issuer to cover the Reporting Person's tax obligations in connection with the vesting event.

F1 · price: The Issuer's Class B Common Stock is convertible into shares of the Issuer's Class A Common Stock on a one-to-one basis at the option of the holders of the Issuer's Class B Common Stock at any time upon written notice to the Issuer, and automatically in the event of certain transfers, including, but not limited to, a transfer of shares to the Issuer.

F1 · derivative.exercise_date: The Issuer's Class B Common Stock is convertible into shares of the Issuer's Class A Common Stock on a one-to-one basis at the option of the holders of the Issuer's Class B Common Stock at any time upon written notice to the Issuer, and automatically in the event of certain transfers, including, but not limited to, a transfer of shares to the Issuer.

F1 · derivative.expiration_date: The Issuer's Class B Common Stock is convertible into shares of the Issuer's Class A Common Stock on a one-to-one basis at the option of the holders of the Issuer's Class B Common Stock at any time upon written notice to the Issuer, and automatically in the event of certain transfers, including, but not limited to, a transfer of shares to the Issuer.

Read SEC document
January 07, 2024 Filed Jan 9, 2024 21:05 UTC
Garipalli VivekDirector · 10% owner
Exercise / conversionClass B Common Stock · Derivative 3,342,698 Not disclosed Not disclosed
Disclosure

SEC source: 0001801170-24-000039 · wk-form4_1704834283.xml · derivative · entry 4

Garipalli Vivek · CIK 0001839260 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,793,675

Underlying: Class A Common Stock · 3,342,698 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: The Issuer's Class B Common Stock is convertible into shares of the Issuer's Class A Common Stock on a one-to-one basis at the option of the holders of the Issuer's Class B Common Stock at any time upon written notice to the Issuer, and automatically in the event of certain transfers, including, but not limited to, a transfer of shares to the Issuer.

F2 · derivative.exercise_price: On January 7, 2024, 20% of the original number of restricted stock units ("RSUs") in respect of a Class B Common Stock granted to the Reported Person on January 7, 2021 vested, with 1,781,633 shares of the Issuer's Class B Common Stock being delivered to the Reporting Person and 1,561,065 shares of the Issuer's Class B Common Stock automatically converting into an equal number of shares of the Issuer's Class A Common Stock and being withheld by the Issuer to cover the Reporting Person's tax obligations in connection with the vesting event.

F1 · price: The Issuer's Class B Common Stock is convertible into shares of the Issuer's Class A Common Stock on a one-to-one basis at the option of the holders of the Issuer's Class B Common Stock at any time upon written notice to the Issuer, and automatically in the event of certain transfers, including, but not limited to, a transfer of shares to the Issuer.

F1 · derivative.exercise_date: The Issuer's Class B Common Stock is convertible into shares of the Issuer's Class A Common Stock on a one-to-one basis at the option of the holders of the Issuer's Class B Common Stock at any time upon written notice to the Issuer, and automatically in the event of certain transfers, including, but not limited to, a transfer of shares to the Issuer.

F1 · derivative.expiration_date: The Issuer's Class B Common Stock is convertible into shares of the Issuer's Class A Common Stock on a one-to-one basis at the option of the holders of the Issuer's Class B Common Stock at any time upon written notice to the Issuer, and automatically in the event of certain transfers, including, but not limited to, a transfer of shares to the Issuer.

Read SEC document
January 07, 2024 Filed Jan 9, 2024 21:05 UTC
Garipalli VivekDirector · 10% owner
Exercise / conversionRestricted Stock Unit · Derivative 3,342,698 Not disclosed Not disclosed
Disclosure

SEC source: 0001801170-24-000039 · wk-form4_1704834283.xml · derivative · entry 3

Garipalli Vivek · CIK 0001839260 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,685,397

Underlying: Class B Common Stock · 3,342,698 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's Class B Common Stock upon settlement for no consideration. The RSU award vests in equal installments on the first five anniversaries of January 7, 2021.

F1 · price: The Issuer's Class B Common Stock is convertible into shares of the Issuer's Class A Common Stock on a one-to-one basis at the option of the holders of the Issuer's Class B Common Stock at any time upon written notice to the Issuer, and automatically in the event of certain transfers, including, but not limited to, a transfer of shares to the Issuer.

F3 · derivative.exercise_date: Each RSU represents a contingent right to receive one share of the Issuer's Class B Common Stock upon settlement for no consideration. The RSU award vests in equal installments on the first five anniversaries of January 7, 2021.

F3 · derivative.expiration_date: Each RSU represents a contingent right to receive one share of the Issuer's Class B Common Stock upon settlement for no consideration. The RSU award vests in equal installments on the first five anniversaries of January 7, 2021.

F3 · derivative.underlying: Each RSU represents a contingent right to receive one share of the Issuer's Class B Common Stock upon settlement for no consideration. The RSU award vests in equal installments on the first five anniversaries of January 7, 2021.

Read SEC document
January 07, 2024 Filed Jan 9, 2024 21:05 UTC
Garipalli VivekDirector · 10% owner
Tax withholdingClass A Common Stock 1,561,065 $0.95 $1,483,011.75
Disclosure

SEC source: 0001801170-24-000039 · wk-form4_1704834283.xml · nonDerivative · entry 2

Garipalli Vivek · CIK 0001839260 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

F1 · security: The Issuer's Class B Common Stock is convertible into shares of the Issuer's Class A Common Stock on a one-to-one basis at the option of the holders of the Issuer's Class B Common Stock at any time upon written notice to the Issuer, and automatically in the event of certain transfers, including, but not limited to, a transfer of shares to the Issuer.

F2 · shares: On January 7, 2024, 20% of the original number of restricted stock units ("RSUs") in respect of a Class B Common Stock granted to the Reported Person on January 7, 2021 vested, with 1,781,633 shares of the Issuer's Class B Common Stock being delivered to the Reporting Person and 1,561,065 shares of the Issuer's Class B Common Stock automatically converting into an equal number of shares of the Issuer's Class A Common Stock and being withheld by the Issuer to cover the Reporting Person's tax obligations in connection with the vesting event.

Read SEC document
January 07, 2024 Filed Jan 9, 2024 21:05 UTC
Garipalli VivekDirector · 10% owner
Exercise / conversionClass A Common Stock 1,561,065 Not disclosed Not disclosed
Disclosure

SEC source: 0001801170-24-000039 · wk-form4_1704834283.xml · nonDerivative · entry 1

Garipalli Vivek · CIK 0001839260 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,561,065

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: The Issuer's Class B Common Stock is convertible into shares of the Issuer's Class A Common Stock on a one-to-one basis at the option of the holders of the Issuer's Class B Common Stock at any time upon written notice to the Issuer, and automatically in the event of certain transfers, including, but not limited to, a transfer of shares to the Issuer.

F2 · shares: On January 7, 2024, 20% of the original number of restricted stock units ("RSUs") in respect of a Class B Common Stock granted to the Reported Person on January 7, 2021 vested, with 1,781,633 shares of the Issuer's Class B Common Stock being delivered to the Reporting Person and 1,561,065 shares of the Issuer's Class B Common Stock automatically converting into an equal number of shares of the Issuer's Class A Common Stock and being withheld by the Issuer to cover the Reporting Person's tax obligations in connection with the vesting event.

F1 · price: The Issuer's Class B Common Stock is convertible into shares of the Issuer's Class A Common Stock on a one-to-one basis at the option of the holders of the Issuer's Class B Common Stock at any time upon written notice to the Issuer, and automatically in the event of certain transfers, including, but not limited to, a transfer of shares to the Issuer.

Read SEC document
January 07, 2024 Filed Jan 9, 2024 21:03 UTC
Soares KarenGeneral Counsel & Secretary
Tax withholdingClass A Common Stock 3,862 $0.95 $3,668.90
Disclosure

SEC source: 0001801170-24-000038 · wk-form4_1704834204.xml · nonDerivative · entry 1

Soares Karen · CIK 0001999086 · General Counsel & Secretary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 996,189

F1 · shares: Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations on January 7, 2024, due to the vesting of 25% of the original number of restricted stock units ("RSUs") granted to the Reporting Person on June 15, 2021. The remaining RSUs will vest on January 7, 2025, subject to the continued service of the Reporting Person on such date.

Read SEC document
January 07, 2024 Filed Jan 9, 2024 21:02 UTC
Reynoso Jamie L.CEO, Medicare Advantage
Tax withholdingClass A Common Stock 16,369 $0.95 $15,550.55
Disclosure

SEC source: 0001801170-24-000037 · wk-form4_1704834129.xml · nonDerivative · entry 1

Reynoso Jamie L. · CIK 0001839066 · CEO, Medicare Advantage

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,485,771

F1 · shares: Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations on January 7, 2024, due to the vesting of 25% of the original number of restricted stock units ("RSUs") granted to the Reporting Person on July 16, 2021, and timely reported on a Form 4 filed on July 20, 2021. The remaining RSUs will vest on January 7, 2025, subject to the continued service of the Reporting Person on such date.

Read SEC document
January 03, 2024 Filed Jan 5, 2024 16:23 UTC
SHAPIRO LEEDirector
GrantClass A Common Stock 206,185 $0.97 $199,999.45
Disclosure

SEC source: 0001801170-24-000026 · wk-form4_1704489768.xml · nonDerivative · entry 1

SHAPIRO LEE · CIK 0001213350 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 537,647

F1 · shares: Represents shares of Class A common stock underlying a time-based restricted stock unit award (RSUs). The RSUs will vest in full on the first anniversary of January 3, 2024, subject to the Reporting Person's continued service as a director through such vesting date.

Read SEC document
January 03, 2024 Filed Jan 5, 2024 22:56 UTC GrantClass A Common Stock 206,185 $0.97 $199,999.45
Disclosure

SEC source: 0001801170-24-000030 · wk-form4_1704495403.xml · nonDerivative · entry 1

Clinton Chelsea · CIK 0001530920 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 541,839

F1 · shares: Represents shares of Class A Common Stock underlying an award of time-based restricted stock units (RSUs). The RSUs will vest in full on the first anniversary of January 3, 2024, subject to the Reporting Person's continued service as a director through such vesting date.

Read SEC document
January 03, 2024 Filed Jan 5, 2024 16:20 UTC GrantClass A Common Stock 206,185 $0.97 $199,999.45
Disclosure

SEC source: 0001801170-24-000025 · wk-form4_1704489606.xml · nonDerivative · entry 1

Robinson William G Jr · CIK 0001604046 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 457,647

F1 · shares: Represents shares of Class A Common Stock underlying an award of time-based restricted stock units (RSUs). The RSUs will vest in full on the first anniversary of January 3, 2024, subject to the Reporting Person's continued service as a director through such vesting date.

Read SEC document
January 03, 2024 Filed Jan 5, 2024 21:30 UTC GrantClass A Common Stock 206,185 $0.97 $199,999.45
Disclosure

SEC source: 0001801170-24-000028 · wk-form4_1704490223.xml · nonDerivative · entry 1

Loengard Anna U · CIK 0001952723 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 401,841

F1 · shares: Represents shares of Class A Common Stock underlying an award of time-based restricted stock units (RSUs). The RSUs will vest in full on the first anniversary of January 3, 2024, subject to the Reporting Person's continued service as a director through such vesting date.

Read SEC document
January 03, 2024 Filed Jan 5, 2024 21:26 UTC GrantClass A Common Stock 206,185 $0.97 $199,999.45
Disclosure

SEC source: 0001801170-24-000027 · wk-form4_1704489990.xml · nonDerivative · entry 1

Edwards Carladenise Armbrister · CIK 0001937412 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 412,252

F1 · shares: Represents shares of Class A Common Stock underlying an award of time-based restricted stock units (RSUs). The RSUs will vest in full on the first anniversary of January 3, 2024, subject to the Reporting Person's continued service as a director through such vesting date.

Read SEC document
January 03, 2024 Filed Jan 5, 2024 21:16 UTC GrantClass A Common Stock 206,185 $0.97 $199,999.45
Disclosure

SEC source: 0001801170-24-000024 · wk-form4_1704489375.xml · nonDerivative · entry 1

Kouzoukas Demetrios L. · CIK 0001856511 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 465,640

F1 · shares: Represents shares of Class A Common Stock underlying an award of time-based restricted stock units (RSUs). The RSUs will vest in full on the first anniversary of January 3, 2024, subject to the Reporting Person's continued service as a director through such vesting date.

Read SEC document
January 03, 2024 Filed Jan 5, 2024 21:07 UTC
Reynoso Jamie L.CEO, Medicare Advantage
Tax withholdingClass A Common Stock 26,240 $0.92 $24,140.80
Disclosure

SEC source: 0001801170-24-000022 · wk-form4_1704488797.xml · nonDerivative · entry 1

Reynoso Jamie L. · CIK 0001839066 · CEO, Medicare Advantage

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,502,140

F1 · shares: Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations due to the vesting on January 3, 2024, of twenty-five percent of the restricted stock units ("RSUs") granted to the Reporting Person on January 3, 2023, and originally reported on a Form 4 filed on January 5, 2023. The remaining RSUs will vest in twelve equal quarterly installments beginning on the date that is three months after January 3, 2024, in each case subject to the continued service of the Reporting Person on each such vesting date.

Read SEC document
January 01, 2024 Filed Jan 3, 2024 21:34 UTC
Toy AndrewDirector · Chief Executive Officer
Tax withholdingClass A Common Stock 1,084,906 $0.95 $1,030,660.70
Disclosure

SEC source: 0001801170-24-000014 · wk-form4_1704317640.xml · nonDerivative · entry 1

Toy Andrew · CIK 0001838733 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,983,445

F1 · shares: Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations on January 1, 2024, due to the vesting of 25% of the original number of restricted stock units (RSUs) granted to the Reporting Person on January 1, 2023, and timely reported on a Form 4 filed on January 4, 2023. The remaining RSUs vest quarterly in equal installments of 6.25%, with the final vesting date occurring on January 1, 2027, subject to the continued service of the Reporting Person on each such vesting date.

Read SEC document
January 01, 2024 Filed Jan 3, 2024 21:33 UTC
Reynoso Jamie L.CEO, Medicare Advantage
Tax withholdingClass A Common Stock 1,559 $0.95 $1,481.05
Disclosure

SEC source: 0001801170-24-000013 · wk-form4_1704317601.xml · nonDerivative · entry 1

Reynoso Jamie L. · CIK 0001839066 · CEO, Medicare Advantage

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,528,380

F1 · shares: Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations due to the vesting on January 1, 2024, of the last third of the number of restricted stock units (RSUs) granted to the Reporting Person on January 31, 2022, upon the achievement of certain performance criteria underlying a performance-based RSU award that was granted on July 16, 2021.

F2 · balance_after: Amount of securities beneficially owned reflects the amount in the Form 4/A filed on January 3, 2024.

Read SEC document
December 15, 2023 Filed Dec 19, 2023 22:09 UTC
Reynoso Jamie L.CEO, Medicare Advantage
Tax withholdingClass A Common Stock 8,691 $0.99 $8,604.09
Disclosure

SEC source: 0001801170-23-000123 · wk-form4_1703023779.xml · nonDerivative · entry 1

Reynoso Jamie L. · CIK 0001839066 · CEO, Medicare Advantage

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,529,825

F1 · shares: Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations upon the vesting, on December 15, 2023, of 6.25% of the original number of RSUs granted to the Reporting Person on September 16, 2022, and timely reported on a Form 4 filed on September 20, 2022. The remaining RSUs vest quarterly in equal installments of 6.25%, with the final vesting date occurring on September 15, 2026, subject to the continued service of the Reporting Person on each such vesting date.

Read SEC document
December 15, 2023 Filed Dec 19, 2023 21:57 UTC
Soares KarenGeneral Counsel & Secretary
Tax withholdingClass A Common Stock 4,361 $0.99 $4,317.39
Disclosure

SEC source: 0001801170-23-000121 · wk-form4_1703023051.xml · nonDerivative · entry 1

Soares Karen · CIK 0001999086 · General Counsel & Secretary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,000,051

F1 · shares: Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations upon the vesting, on December 15, 2023, of 6.25% of the original number of time-based restricted stock units ("RSUs") granted to the Reporting Person on September 15, 2022. The remaining RSUs vest quarterly in equal installments of 6.25%, with a final vesting date occurring on September 15, 2026, subject to the continued service of the Reporting Person on each such vesting date.

Read SEC document
December 14, 2023 Filed Dec 18, 2023 21:52 UTC
Wai ConradChief Technology Officer
Tax withholdingClass A Common Stock 96,086 $1.00 $96,086.00
Disclosure

SEC source: 0001801170-23-000119 · wk-form4_1702936350.xml · nonDerivative · entry 1

Wai Conrad · CIK 0001971702 · Chief Technology Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,997,139

F1 · shares: Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations upon the vesting, on December 14, 2023, of 6.25% of the original number of time-based restricted stock units ("RSUs") granted to the Reporting Person on March 14, 2022. The remaining RSUs will vest quarterly in equal installments of 6.25%, with the final vesting date occurring on March 14, 2026, subject to the continued service of the Reporting Person on each such vesting date.

Read SEC document
December 14, 2023 Filed Dec 18, 2023 21:51 UTC
Reynoso Jamie L.Chief Operating Officer
Tax withholdingClass A Common Stock 12,567 $1.00 $12,567.00
Disclosure

SEC source: 0001801170-23-000118 · wk-form4_1702936289.xml · nonDerivative · entry 1

Reynoso Jamie L. · CIK 0001839066 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,538,516

F1 · shares: Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations upon the vesting, on December 14, 2023, of 6.25% of the original number of time-based restricted stock units ("RSUs") granted to the Reporting Person on March 14, 2022, and timely reported on a Form 4 filed on March 16, 2022. The remaining RSUs vest quarterly in equal installments of 6.25%, with the final vesting date occurring on March 14, 2026, subject to the continued service of the Reporting Person on each such vesting date.

Read SEC document
November 14, 2023 Filed Nov 16, 2023 21:42 UTC
Soares KarenGeneral Counsel & Secretary
Tax withholdingClass A Common Stock 5,079 $1.01 $5,129.79
Disclosure

SEC source: 0001801170-23-000111 · wk-form4_1700170939.xml · nonDerivative · entry 1

Soares Karen · CIK 0001999086 · General Counsel & Secretary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,004,412

F1 · shares: Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations upon the vesting, on November 14, 2023, of 6.25% of the original number of time-based restricted stock units ("RSUs") granted to the Reporting Person on February 14, 2022. The remaining RSUs vest quarterly in equal installments of 6.25%, with a final vesting date occurring on February 14, 2026, subject to the continued service of the Reporting Person on each such vesting date.

Read SEC document
November 09, 2023 Filed Nov 13, 2023 21:24 UTC
Sharp Aric RCEO of Value Based Care
Tax withholdingClass A Common Stock 10,515 $0.88 $9,253.20
Disclosure

SEC source: 0001801170-23-000109 · wk-form4_1699910641.xml · nonDerivative · entry 1

Sharp Aric R · CIK 0001926602 · CEO of Value Based Care

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,803,540

F1 · shares: Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations upon the vesting, on November 9, 2023, of 6.25% of the original number of time-based restricted stock units ("RSUs") granted to the Reporting Person on May 9, 2022, and timely reported on a Form 4 filed on May 10, 2022. The remaining RSUs will vest quarterly in equal installments of 6.25%, with the final vesting date occurring on May 9, 2026, subject to the continued service of the Reporting Person on each such vesting date.

Read SEC document
November 08, 2023 Filed Nov 13, 2023 21:19 UTC
Toy AndrewDirector · Chief Executive Officer
Tax withholdingClass A Common Stock 83,514 $0.90 $75,162.60
Disclosure

SEC source: 0001801170-23-000108 · wk-form4_1699910340.xml · nonDerivative · entry 1

Toy Andrew · CIK 0001838733 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,068,351

F1 · shares: Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations upon the vesting, on November 8, 2023, of 6.25% of the original number of time-based restricted stock units ("RSUs") granted to the Reporting Person on August 8, 2022, and timely reported on a Form 4 filed on August 10, 2022. The remaining RSUs vest quarterly in equal installments of 6.25%, with a final vesting date occurring on August 8, 2026, subject to the continued service of the Reporting Person on each such vesting date.

Read SEC document
October 31, 2023 Filed Nov 2, 2023 20:42 UTC
Leffler Scott J.Chief Financial Officer
GrantClass A Common Stock 400,000 $0.00 $0.00
Disclosure

SEC source: 0001801170-23-000092 · wk-form4_1698957760.xml · nonDerivative · entry 1

Leffler Scott J. · CIK 0001832406 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,940,841

F1 · shares: Represents shares of Class A common stock underlying a time-based restricted stock unit award ("RSUs"). Fifty percent of the RSUs will vest on the first anniversary of October 31, 2023, and the remaining RSUs will vest in four equal quarterly installments beginning on the date that is three months after the first anniversary of October 31, 2023, in each case subject to the continued service of the Reporting Person on each such vesting date, so that such RSUs will be fully vested on October 31, 2025.

Read SEC document
October 31, 2023 Filed Nov 2, 2023 20:42 UTC
Priest Brady PatrickCEO of Home Care
GrantClass A Common Stock 440,000 $0.00 $0.00
Disclosure

SEC source: 0001801170-23-000091 · wk-form4_1698957714.xml · nonDerivative · entry 1

Priest Brady Patrick · CIK 0001938197 · CEO of Home Care

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,969,061

F1 · shares: Represents shares of Class A common stock underlying a time-based restricted stock unit award ("RSUs"). Fifty percent of the RSUs will vest on the first anniversary of October 31, 2023, and the remaining RSUs will vest in four equal quarterly installments beginning on the date that is three months after the first anniversary of October 31, 2023, in each case subject to the continued service of the Reporting Person on each such vesting date, so that such RSUs will be fully vested on October 31, 2025.

Read SEC document
October 31, 2023 Filed Nov 2, 2023 20:37 UTC
Sharp Aric RCEO of Value Based Care
GrantClass A Common Stock 250,000 $0.00 $0.00
Disclosure

SEC source: 0001801170-23-000087 · wk-form4_1698957416.xml · nonDerivative · entry 1

Sharp Aric R · CIK 0001926602 · CEO of Value Based Care

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,814,055

F1 · shares: Represents shares of Class A common stock underlying a time-based restricted stock unit award ("RSUs"). Fifty percent of the RSUs will vest on the first anniversary of October 31, 2023, and the remaining RSUs will vest in four equal quarterly installments beginning on the date that is three months after the first anniversary of October 31, 2023, in each case subject to the continued service of the Reporting Person on each such vesting date, so that such RSUs will be fully vested on October 31, 2025.

Read SEC document
October 31, 2023 Filed Nov 2, 2023 20:39 UTC
CLOVER HEALTH INVESTMENTS, CORP. /DEChief Technology Officer
GrantClass A Common Stock 440,000 $0.00 $0.00
Disclosure

SEC source: 0001801170-23-000089 · wk-form4_1698957574.xml · nonDerivative · entry 1

CLOVER HEALTH INVESTMENTS, CORP. /DE · CIK 0001801170 · Chief Technology Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,093,225

F1 · shares: Represents shares of Class A common stock underlying a time-based restricted stock unit award ("RSUs"). Fifty percent of the RSUs will vest on the first anniversary of October 31, 2023, and the remaining RSUs will vest in four equal quarterly installments beginning on the date that is three months after the first anniversary of October 31, 2023, in each case subject to the continued service of the Reporting Person on each such vesting date, so that such RSUs will be fully vested on October 31, 2025.

Read SEC document
October 31, 2023 Filed Nov 2, 2023 20:41 UTC
Reynoso Jamie L.Chief Operating Officer
GrantClass A Common Stock 600,000 $0.00 $0.00
Disclosure

SEC source: 0001801170-23-000090 · wk-form4_1698957676.xml · nonDerivative · entry 1

Reynoso Jamie L. · CIK 0001839066 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,551,083

F1 · shares: Represents shares of Class A common stock underlying a time-based restricted stock unit award ("RSUs"). Fifty percent of the RSUs will vest on the first anniversary of October 31, 2023, and the remaining RSUs will vest in four equal quarterly installments beginning on the date that is three months after the first anniversary of October 31, 2023, in each case subject to the continued service of the Reporting Person on each such vesting date, so that such RSUs will be fully vested on October 31, 2025.

Read SEC document
October 31, 2023 Filed Nov 2, 2023 20:38 UTC
Soares KarenGeneral Counsel & Secretary
GrantClass A Common Stock 600,000 $0.00 $0.00
Disclosure

SEC source: 0001801170-23-000088 · wk-form4_1698957522.xml · nonDerivative · entry 1

Soares Karen · CIK 0001999086 · General Counsel & Secretary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,009,491

F1 · shares: Represents shares of Class A common stock underlying a time-based restricted stock unit award ("RSUs"). Fifty percent of the RSUs will vest on the first anniversary of October 31, 2023, and the remaining RSUs will vest in four equal quarterly installments beginning on the date that is three months after the first anniversary of October 31, 2023, in each case subject to the continued service of the Reporting Person on each such vesting date, so that such RSUs will be fully vested on October 31, 2025.

Read SEC document
October 31, 2023 Filed Nov 3, 2023 21:00 UTC Amendment
Wai ConradChief Technology Officer
GrantClass A Common Stock 440,000 $0.00 $0.00
Disclosure

SEC source: 0001801170-23-000096 · wk-form4a_1699045230.xml · nonDerivative · entry 1

Wai Conrad · CIK 0001971702 · Chief Technology Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,093,225

F1 · security: This Form 4/A amends the original Form 4, filed on November 2, 2023, solely to correct the CIK for the Reporting Person. The original Form 4 inadvertently included the Registrant's CIK.

Read SEC document
October 25, 2023 Filed Oct 27, 2023 20:21 UTC
Leffler Scott J.Chief Financial Officer
Tax withholdingClass A Common Stock 124,002 $0.91 $112,841.82
Disclosure

SEC source: 0001801170-23-000070 · wk-form4_1698438053.xml · nonDerivative · entry 1

Leffler Scott J. · CIK 0001832406 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,540,841

F1 · shares: Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations upon the vesting, on October 25, 2023, of 6.25% of the original number of time-based restricted stock units ("RSUs") granted to the Reporting Person on July 25, 2022, and timely reported on a Form 4 filed on July 26, 2022. The remaining RSUs vest quarterly in equal installments of 6.25%, with the final vesting date occurring on July 25, 2026, subject to the continued service of the Reporting Person on such vesting date.

Read SEC document
October 18, 2023 Filed Oct 20, 2023 21:21 UTC
Priest Brady PatrickCEO of Home Care
Tax withholdingClass A Common Stock 32,416 $0.99 $32,091.84
Disclosure

SEC source: 0001801170-23-000067 · wk-form4_1697836823.xml · nonDerivative · entry 1

Priest Brady Patrick · CIK 0001938197 · CEO of Home Care

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,529,061

F1 · shares: Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations upon the vesting, on October 18, 2023, of 6.25% of the original number of time-based restricted stock units ("RSUs") granted to the Reporting Person on July 18, 2022, and timely reported on a Form 4 filed on July 19, 2022. The remaining RSUs vest quarterly in equal installments of 6.25%, with the final vesting date occurring on July 18, 2026, subject to the continued service of the Reporting Person on such vesting date.

Read SEC document
September 15, 2023 Filed Sep 18, 2023 21:19 UTC
Reynoso Jamie L.CEO of Medicare Advantage
Tax withholdingClass A Common Stock 21,511 $1.13 $24,307.43
Disclosure

SEC source: 0000895345-23-000533 · form4.xml · nonDerivative · entry 2

Reynoso Jamie L. · CIK 0001839066 · CEO of Medicare Advantage

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,951,083

F2 · shares: Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations upon the vesting, on September 15, 2023, of 25% of the original number of RSUs granted to the Reporting Person on September 16, 2022, and timely reported on a Form 4 filed on September 20, 2022. The remaining RSUs will vest in twelve equal quarterly installments beginning on the date that is three months after September 15, 2023, in each case subject to the continued service of the Reporting Person on such vesting date.

Read SEC document
September 14, 2023 Filed Sep 18, 2023 21:20 UTC
Wai ConradChief Technology Officer
Tax withholdingClass A Common Stock 96,086 $1.13 $108,577.18
Disclosure

SEC source: 0000895345-23-000534 · form4.xml · nonDerivative · entry 1

Wai Conrad · CIK 0001971702 · Chief Technology Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,653,225

F1 · shares: Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations upon the vesting, on September 14, 2023, of 6.25% of the original number of time-based restricted stock units ("RSUs") granted to the Reporting Person on March 14, 2022. The remaining RSUs will vest quarterly in equal installments of 6.25%, with the final vesting date occurring on March 14, 2026, subject to the continued service of the Reporting Person on each such vesting date.

Read SEC document
September 14, 2023 Filed Sep 18, 2023 21:19 UTC
Reynoso Jamie L.CEO of Medicare Advantage
Tax withholdingClass A Common Stock 7,776 $1.13 $8,786.88
Disclosure

SEC source: 0000895345-23-000533 · form4.xml · nonDerivative · entry 1

Reynoso Jamie L. · CIK 0001839066 · CEO of Medicare Advantage

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,972,594

F1 · shares: Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations upon the vesting, on September 14, 2023, of 6.25% of the original number of time-based restricted stock units ("RSUs") granted to the Reporting Person on March 14, 2022, and timely reported on a Form 4 filed on March 16, 2022. The remaining RSUs vest quarterly in equal installments of 6.25%, with the final vesting date occurring on March 14, 2026, subject to the continued service of the Reporting Person on each such vesting date.

Read SEC document
September 07, 2023 Filed Sep 11, 2023 20:10 UTC
Sharp Aric RCEO of Value-Based Care
Tax withholdingClass A Common Stock 138,477 $1.31 $181,404.87
Disclosure

SEC source: 0000895345-23-000529 · form4.xml · nonDerivative · entry 2

Sharp Aric R · CIK 0001926602 · CEO of Value-Based Care

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,564,055

F2 · shares: Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations due to the vesting of 1/3 of the number of earned restricted stock units, as described above.

Read SEC document
September 07, 2023 Filed Sep 11, 2023 20:10 UTC
Sharp Aric RCEO of Value-Based Care
GrantClass A Common Stock 1,368,750 $0.00 $0.00
Disclosure

SEC source: 0000895345-23-000529 · form4.xml · nonDerivative · entry 1

Sharp Aric R · CIK 0001926602 · CEO of Value-Based Care

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,702,532

F1 · shares: Represents restricted stock units, each representing a right to a share of Class A Common Stock, earned in connection with the determination of the level of performance achievement in satisfaction of vesting conditions underlying a performance-based restricted share unit grant awarded on November 30, 2022. One-third of the number of earned restricted stock units vested and was settled on September 7, 2023, and 1/3 of the number of earned restricted stock units will vest on each of June 30, 2024 and June 30, 2025, subject to the reporting person's continued employment through each vesting date.

Read SEC document
September 07, 2023 Filed Sep 11, 2023 20:11 UTC
Reynoso Jamie L.CEO of Medicare Advantage
Tax withholdingClass A Common Stock 52,967 $1.31 $69,386.77
Disclosure

SEC source: 0000895345-23-000530 · form4.xml · nonDerivative · entry 2

Reynoso Jamie L. · CIK 0001839066 · CEO of Medicare Advantage

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,980,370

F2 · shares: Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations due to the vesting of 1/3 of the number of earned restricted stock units, as described above.

Read SEC document
September 07, 2023 Filed Sep 11, 2023 20:11 UTC
Reynoso Jamie L.CEO of Medicare Advantage
GrantClass A Common Stock 652,452 $0.00 $0.00
Disclosure

SEC source: 0000895345-23-000530 · form4.xml · nonDerivative · entry 1

Reynoso Jamie L. · CIK 0001839066 · CEO of Medicare Advantage

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,033,337

F1 · shares: Represents restricted stock units, each representing a right to a share of Class A Common Stock, earned in connection with the determination of the level of performance achievement in satisfaction of vesting conditions underlying a performance-based restricted share unit grant awarded on March 16, 2023. One-third of the number of earned restricted stock units vested and was settled on September 7, 2023, and 1/3 of the number of earned restricted stock units will vest on each of June 30, 2024 and June 30, 2025, subject to the reporting person's continued employment through each vesting date.

Read SEC document
September 07, 2023 Filed Jan 3, 2024 21:30 UTC Amendment
Reynoso Jamie L.CEO, Medicare Advantage
GrantClass A Common Stock 652,566 $0.00 $0.00
Disclosure

SEC source: 0001801170-24-000012 · wk-form4a_1704317375.xml · nonDerivative · entry 1

Reynoso Jamie L. · CIK 0001839066 · CEO, Medicare Advantage

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,033,451

F1 · shares: This Form 4/A is being filed solely to correct the number of restricted stock units (RSUs) received upon determination of the level of performance, as described in Footnote 2 below.

F2 · shares: Represents RSUs, each representing a right to a share of Class A Common Stock, earned in connection with the determination of the level of performance achievement in satisfaction of vesting conditions underlying a performance-based restricted share unit grant awarded on March 16, 2023. One-third of the number of earned RSUs vested and were settled on September 7, 2023, and one-third of the number of earned RSUs will vest on each of June 30, 2024, and June 30, 2025, subject to the Reporting Person's continued employment through each vesting date.

Read SEC document
September 06, 2023 Filed Sep 8, 2023 20:18 UTC PurchaseClass A Common Stock 500 $1.30 $650.00
Disclosure

SEC source: 0000895345-23-000526 · form4.xml · nonDerivative · entry 4

Loengard Anna U · CIK 0001952723 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · By Daughter in a Custodial Account

Disclosed balance after: 1,500

Read SEC document
September 06, 2023 Filed Sep 8, 2023 20:18 UTC PurchaseClass A Common Stock 500 $1.30 $650.00
Disclosure

SEC source: 0000895345-23-000526 · form4.xml · nonDerivative · entry 3

Loengard Anna U · CIK 0001952723 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · By Son in a Custodial Account

Disclosed balance after: 1,300

Read SEC document
September 06, 2023 Filed Sep 8, 2023 20:18 UTC PurchaseClass A Common Stock 10,000 $1.30 $13,000.00
Disclosure

SEC source: 0000895345-23-000526 · form4.xml · nonDerivative · entry 2

Loengard Anna U · CIK 0001952723 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · By Spouse IRA

Disclosed balance after: 10,000

Read SEC document
August 09, 2023 Filed Aug 10, 2023 20:28 UTC
Sharp Aric RCEO of Value-Based Care
Tax withholdingClass A Common Stock 7,037 $1.39 $9,781.43
Disclosure

SEC source: 0000895345-23-000456 · form4.xml · nonDerivative · entry 1

Sharp Aric R · CIK 0001926602 · CEO of Value-Based Care

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 335,782

F1 · shares: Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations upon the vesting, on August 9, 2023, of 6.25% of the original number of time-based restricted stock units ("RSUs") granted to the Reporting Person on May 9, 2022, and timely reported on a Form 4 filed on May 10, 2022. The remaining RSUs will vest quarterly in equal installments of 6.25%, with the final vesting date occurring on May 9, 2026, subject to the continued service of the Reporting Person on each such vesting date.

Read SEC document
August 08, 2023 Filed Aug 9, 2023 20:46 UTC
Toy AndrewDirector · Chief Executive Officer
Tax withholdingClass A Common Stock 277,720 $1.33 $369,367.60
Disclosure

SEC source: 0000895345-23-000452 · form4.xml · nonDerivative · entry 1

Toy Andrew · CIK 0001838733 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,151,865

F1 · shares: Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations upon the vesting, on August 8, 2023, of 25% of the original number of time-based restricted stock units ("RSUs") granted to the Reporting Person on August 8, 2022, and timely reported on a Form 4 filed on August 10, 2022. The remaining RSUs will vest in twelve equal quarterly installments beginning on the date that is three months after August 8, 2023, in each case subject to the continued service of the Reporting Person on such vesting date.

Read SEC document
July 25, 2023 Filed Jul 26, 2023 20:50 UTC
Leffler Scott J.Chief Financial Officer
Tax withholdingClass A Common Stock 387,173 $1.09 $422,018.57
Disclosure

SEC source: 0000895345-23-000420 · form4.xml · nonDerivative · entry 1

Leffler Scott J. · CIK 0001832406 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,664,843

F1 · shares: Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations upon the vesting, on July 25, 2023, of 25% of the original number of time-based restricted stock units ("RSUs") granted to the Reporting Person on July 25, 2022, and timely reported on a Form 4 filed on July 25, 2022. The remaining RSUs vest in twelve equal quarterly installments beginning on the date that is three months after July 25, 2023, in each case subject to the continued service of the Reporting Person on such vesting date.

Read SEC document
July 18, 2023 Filed Jul 20, 2023 22:02 UTC
Priest Brady PatrickCEO of Home Care
Tax withholdingClass A Common Stock 133,438 $1.06 $141,444.28
Disclosure

SEC source: 0000895345-23-000414 · form4.xml · nonDerivative · entry 1

Priest Brady Patrick · CIK 0001938197 · CEO of Home Care

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,561,477

F1 · shares: Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations upon the vesting, on July 18, 2023, of 25% of the original number of time-based restricted stock units ("RSUs") granted to the Reporting Person on July 18, 2022, and timely reported on a Form 4 filed on July 19, 2022. The remaining RSUs vest in twelve equal quarterly installments beginning on the date that is three months after July 18, 2023, in each case subject to the continued service of the Reporting Person on such vesting date.

Read SEC document
June 14, 2023 Filed Jun 16, 2023 16:03 UTC
Martin Joseph RichardsGeneral Counsel
Tax withholdingClass A Common Stock 98,827 $0.94 $92,897.38
Disclosure

SEC source: 0000895345-23-000391 · form4.xml · nonDerivative · entry 1

Martin Joseph Richards · CIK 0001776869 · General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,718,857

F1 · shares: Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations upon the vesting, on June 16, 2023, of 6.25% of the original number of time-based restricted stock units ("RSUs") granted to the Reporting Person on March 14, 2022, and timely reported on a Form 4 filed on March 15, 2022. The remaining RSUs will vest quarterly in equal installments of 6.25%, with the final vesting date occurring on March 17, 2026, subject to the continued service of the Reporting Person on each such vesting date.

Read SEC document
June 14, 2023 Filed Jun 16, 2023 20:04 UTC
Reynoso Jamie L.CEO of Medicare Advantage
Tax withholdingClass A Common Stock 7,776 $0.94 $7,309.44
Disclosure

SEC source: 0000895345-23-000392 · form4.xml · nonDerivative · entry 1

Reynoso Jamie L. · CIK 0001839066 · CEO of Medicare Advantage

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,380,885

F1 · shares: Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations upon the vesting, on June 16, 2023, of 6.25% of the original number of time-based restricted stock units ("RSUs") granted to the Reporting Person on March 14, 2022, and timely reported on a Form 4 filed on March 16, 2022. The remaining RSUs will vest quarterly in equal installments of 6.25%, with the final vesting date occurring on March 17, 2026, subject to the continued service of the Reporting Person on each such vesting date.

Read SEC document
June 14, 2023 Filed Jun 16, 2023 20:02 UTC
Wai ConradChief Technology Officer
Tax withholdingClass A Common Stock 86,763 $0.94 $81,557.22
Disclosure

SEC source: 0000895345-23-000390 · form4.xml · nonDerivative · entry 1

Wai Conrad · CIK 0001971702 · Chief Technology Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,749,311

F1 · shares: Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations upon the vesting, on June 16, 2023, of 6.25% of the original number of time-based restricted stock units ("RSUs") granted to the Reporting Person on March 14, 2022. The remaining RSUs will vest quarterly in equal installments of 6.25%, with the final vesting date occurring on March 17, 2026, subject to the continued service of the Reporting Person on each such vesting date.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.